XML 53 R37.htm IDEA: XBRL DOCUMENT v3.23.3
Income Taxes (Tables)
12 Months Ended
Jul. 31, 2023
Income Tax Disclosure [Abstract]  
Income before provision for income taxes
Loss before benefit from income taxes consists of the following:
 Fiscal Years Ended July 31,
 202320222021
U.S.$(21,327,000)(31,772,000)(73,153,000)
Foreign(9,520,000)(5,303,000)(1,827,000)
 $(30,847,000)(37,075,000)(74,980,000)
Provision for income taxes
The (benefit from) provision for income taxes included in the accompanying Consolidated Statements of Operations consists of the following:
 Fiscal Years Ended July 31,
 202320222021
Federal – current$(258,000)287,000 608,000 
Federal – deferred(4,623,000)(4,888,000)(877,000)
State and local – current1,412,000 348,000 466,000 
State and local – deferred(815,000)(442,000)(598,000)
Foreign – current958,000 1,197,000 688,000 
Foreign – deferred(622,000)(525,000)(1,787,000)
Benefit from income taxes$(3,948,000)(4,023,000)(1,500,000)
Provision for income taxes differed from amounts computed by applying the U.S. Federal income tax rate The benefit from income taxes differed from the amounts computed by applying the U.S. Federal income tax rate as a result of the following:
 Fiscal Years Ended July 31,
 202320222021
 AmountRateAmountRateAmountRate
Computed "expected" tax benefit$(6,478,000)21.0 %(7,786,000)21.0 %(15,746,000)21.0 %
Increase (reduction) in income taxes resulting from:      
State and local income taxes, net of federal benefit440,000 (1.4)227,000 (0.6)(1,371,000)1.8 
Stock-based compensation692,000 (2.2)1,049,000 (2.8)(20,000)— 
Research and experimentation credits(2,576,000)8.4 (1,484,000)4.0 (1,018,000)1.4 
Foreign-derived intangible income deduction(517,000)1.7 — — 164,000 (0.2)
Revaluation of convertible preferred stock option liability— — (211,000)0.6 — — 
Nondeductible transaction costs— — — — 402,000 (0.5)
Nondeductible executive compensation1,484,000 (4.8)2,801,000 (7.6)628,000 (0.8)
Fines and penalties— — (1,000)— — — 
Audit settlements— — 18,000 — 6,000 — 
Change in the beginning of the year valuation allowance for deferred tax assets— — — — (805,000)1.1 
Change in valuation allowance2,834,000 (9.2)2,009,000 (5.4)15,582,000 (20.8)
Remeasurement of deferred taxes— — (396,000)1.1 (224,000)0.3 
Foreign income taxes(269,000)0.9 (478,000)1.3 676,000 (0.9)
Other, net442,000 (1.6)229,000 (0.7)226,000 (0.4)
Benefit from income taxes$(3,948,000)12.8 %(4,023,000)10.9 %(1,500,000)2.0 %
Tax effects of temporary differences
The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities at July 31, 2023 and 2022 are presented below:
 20232022
Deferred tax assets:  
Inventory and warranty reserves$6,147,000 5,970,000 
Compensation and commissions3,221,000 4,376,000 
Federal, state and foreign research and experimentation credits19,308,000 19,476,000 
Capitalized U.S. research and experimental expenditures8,784,000 — 
Stock-based compensation4,774,000 3,950,000 
Foreign scientific research and experimental development expenditures2,118,000 1,890,000 
Federal, state and foreign net operating losses13,011,000 14,481,000 
Federal and state capital losses15,582,000 15,582,000 
Lease liabilities11,986,000 12,595,000 
Deferred revenue, non-current4,463,000 2,194,000 
Other2,417,000 3,725,000 
Less: valuation allowance(34,478,000)(31,227,000)
Total deferred tax assets57,333,000 53,012,000 
 Deferred tax liabilities:  
Plant and equipment(4,883,000)(3,489,000)
Lease right-of-use assets(10,510,000)(11,801,000)
Intangibles(50,843,000)(52,681,000)
Total deferred tax liabilities(66,236,000)(67,971,000)
Net deferred tax liabilities$(8,903,000)(14,959,000)
Summary of unrecognized tax benefits The following table summarizes the activity related to our unrecognized tax benefits for fiscal years 2023, 2022 and 2021 (excluding interest):
 202320222021
Balance at beginning of period$9,675,000 9,009,000 8,270,000 
Increase related to current period681,000 598,000 528,000 
Increase related to prior periods51,000 153,000 338,000 
Expiration of statute of limitations(1,406,000)(83,000)(48,000)
Decrease related to prior periods(45,000)(2,000)(79,000)
Balance at end of period$8,956,000 9,675,000 9,009,000